Parellada Cintia Irene, Abreu Ariane de Jesus Lopes de, Birck Marina G, Dias Carolina Zampirolli, Moreira Thais das Neves Fraga, Julian Guilherme Silva, Batista Paula de Mendonça, Orengo Juan Carlos, Bierrenbach Ana Luiza
MSD Brazil, São Paulo 04583-110, Brazil.
IQVIA Brazil, São Paulo 04719-002, Brazil.
Vaccines (Basel). 2023 Jul 25;11(8):1279. doi: 10.3390/vaccines11081279.
The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal pneumococcal vaccination for older adults has not been implemented yet. Our aim is to evaluate the trends in pneumococcal meningitis incidence and case fatality rate (CFR) across all age groups from 2007 to 2019 using data from the National Surveillance System. The pre-PCV (2007-2009) and post-PCV (2011-2019) periods were compared; changes in incidence and CFR were assessed by joinpoint regression. Additional analyses of bacterial meningitis were performed to compare the patterns and trends. Over the 13-year period, 81,203 and 13,837 cases were classified as bacterial and pneumococcal meningitis, respectively. was the main etiological agent of bacterial meningitis in adults aged ≥50 years and the most lethal in all age groups. In the post-PCV period, a 56.5% reduction in the average incidence was seen in pneumococcal meningitis in the pediatric population. In contrast, there was an increasing trend among adults. The CFR for pneumococcal and bacterial meningitis remained stable in most age groups during the study period. These findings highlight the value of expanding pneumococcal vaccination policies, including vaccines that provide better indirect protection from children to adults and broadening vaccination to older adults.
肺炎球菌结合疫苗(PCV)于2010年被纳入巴西儿童国家免疫规划;然而,针对老年人的普遍肺炎球菌疫苗接种尚未实施。我们的目的是利用国家监测系统的数据评估2007年至2019年所有年龄组肺炎球菌脑膜炎发病率和病死率(CFR)的趋势。比较了PCV接种前(2007 - 2009年)和接种后(2011 - 2019年)两个时期;通过连接点回归评估发病率和CFR的变化。对细菌性脑膜炎进行了额外分析以比较模式和趋势。在这13年期间,分别有81203例和13837例病例被分类为细菌性脑膜炎和肺炎球菌脑膜炎。肺炎球菌是≥50岁成年人细菌性脑膜炎的主要病原体,且在所有年龄组中致死率最高。在PCV接种后时期,儿童人群中肺炎球菌脑膜炎的平均发病率下降了56.5%。相比之下,成年人中则呈上升趋势。在研究期间,大多数年龄组的肺炎球菌脑膜炎和细菌性脑膜炎的CFR保持稳定。这些发现凸显了扩大肺炎球菌疫苗接种政策的价值,包括提供从儿童到成人更好间接保护的疫苗以及将疫苗接种扩大到老年人。